New patent for Emergent drug NARCAN

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for NARCAN
Annual Drug Patent Expirations for NARCAN

Narcan is a drug marketed by Adapt, Bristol Myers Squibb, and Emergent and, and is included in five NDAs. It is available from seven suppliers. There are eight patents protecting this drug and two Paragraph IV challenges.

NARCAN drug price trends.

Drug patent litigation for NARCAN.

This drug has twenty-eight patent family members in fourteen countries.

The generic ingredient in NARCAN is naloxone hydrochloride. Seven suppliers are listed for this compound. Additional details are available on the naloxone hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top